发明申请
US20050256157A1 Combination therapy with CHK1 inhibitors 审中-公开
与CHK1抑制剂组合治疗

Combination therapy with CHK1 inhibitors
摘要:
Compounds of Structure I, and salts, tautomers, stereoisomers, and mixtures thereof may be used in methods of inhibiting checkpoint kinase 1 in subjects, in methods for inducing cell cycle progression, and in methods for increasing apoptosis in cells. Such compounds may be used to prepare pharmaceutical compositions and may be used in conjunction with DNA damaging agents.
信息查询
0/0